References in this Quarterly Report on Form
10-Q
for the three months ended March 31, 2022 (the "Quarterly Report") to "we,"
"our," "us" or the "Company" refer to Arena Fortify Acquisition Corp. References
to our "management" or our "management team" refer to our officers and
directors, and references to the "Sponsor" refer to Arena Fortify Sponsor LLC.
The following discussion and analysis of the Company's financial condition and
results of operations should be read in conjunction with the unaudited condensed
financial statements and the notes thereto contained elsewhere in this Quarterly
Report. Certain information contained in the discussion and analysis set forth
below includes forward-looking statements that involve risks, uncertainties and
assumptions. In light of these risks, uncertainties and assumptions, the
forward-looking events discussed may not occur. See "Cautionary Statement
Regarding Forward-Looking Statements." Also, see the risk factors and other
cautionary statements described under the heading "Item 1A. Risk Factors." We do
not undertake any obligation to publicly update any forward-looking statements
except as otherwise required by applicable law.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes "forward-looking statements" that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this "Management's Discussion and Analysis of Financial Condition and Results of Operations" regarding the Company's financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as "expect," "believe," "anticipate," "intend," "estimate," "seek" and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management's current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company's final prospectus for its Initial Public Offering (as defined below) filed with the U.S. Securities and Exchange Commission (the "SEC"). The Company's securities filings can be accessed on the EDGAR section of the SEC's website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company incorporated as a Delaware corporation on January 26, 2021 and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to herein as our initial business combination. We have not selected any specific business combination target. We intend to effectuate our initial business combination using cash from the proceeds of our initial public offering (the "Initial Public Offering"), the Initial Stockholder Loans, and the private placement of the Private Placement Warrants (as defined below), the proceeds of the sale of our shares in connection with our initial business combination (pursuant to forward purchase agreements or backstop agreements we may enter into following the consummation of the Initial Public Offering or otherwise), shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination of the foregoing.

In February 2021, we issued 5,750,000 founder shares to our Sponsor for an aggregate purchase price of $25,000 in cash, or approximately $0.004 per share. In March 2021, our Sponsor sold 456,000 founder shares each to Cowen Investments II LLC ("Cowen") and Intrepid Financial Partners, L.L.C. ("Intrepid" and with the Sponsor and Cowen, the "Initial Stockholders"). On March 19, 2021, our Sponsor transferred 25,000 shares to each of Marc McCarthy and James Crockard III. On October 4, 2021, we effected a share contribution back to capital resulting in our Initial Stockholders holding 4,312,500 shares of our Class B common stock.



On November 15, 2021, we consummated the Initial Public Offering of 17,250,000
units (including 2,250,000 units issued upon exercise in full by the
underwriters of their option to purchase additional units), at $10.00 per unit,
generating gross proceeds of $172,500,000. Each unit consists of one share of
Class A common stock, $0.0001 par value, and
one-half
of one redeemable warrant ("Public Warrant"). Each Public Warrant entitles the
holder to purchase one share of Class A common stock at an exercise price of
$11.50 per whole share.

Certain of our Initial Stockholders lent us an aggregate amount of $3,450,000 as of the closing date of our Initial Public Offering at no interest pursuant to those certain promissory notes (collectively, the "Initial Stockholder Loan Notes"). The proceeds of the Initial Stockholder Loans were added to the trust account and will be used to fund the redemption of our public shares (subject to the requirements of applicable law). The Initial Stockholder Loans shall be repaid in cash or converted into warrants (the "Initial Stockholder Loan Warrants") at a conversion price of $1.00 per warrant, at each Initial Stockholder's sole discretion. The Initial Stockholder Loan Warrants would be identical to the Private Placement Warrants sold in connection with our Initial Public Offering.

Simultaneously with the closing of the Initial Public Offering, our initial stockholders purchased an aggregate of 5,450,000 private placement warrants (including 450,000 private placement warrants issued in connection with the exercise in full by the underwriters of their option to purchase additional units), at a price of $1.00 per private placement warrant (the "Private Placement Warrants") ($5,450,000 in the aggregate) in a private placement (the "Private Placement"). Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share.


                                       22

--------------------------------------------------------------------------------

Table of Contents


Following our Initial Public Offering, the closing of the over-allotment option,
the sale of the Private Placement Warrants, and the receipt of proceeds from the
Initial Stockholder Loans, approximately $175.9 million was placed in a trust
account located in the United States with Continental Stock Transfer & Trust
Company acting as trustee, and invested only in U.S. "government securities"
within the meaning of Section 2(a)(16) of the Investment Company Act having a
maturity of 185 days or less or in money market funds meeting certain conditions
under Rule
2a-7
promulgated under the Investment Company Act which invest only in direct U.S.
government treasury obligations, as determined by us, until the earlier of:
(i) the completion of a business combination and (ii) the distribution of the
trust account.

If we are unable to complete an initial business combination within 15 months
from the closing of our Initial Public Offering, or February 15, 2023, we will
(i) cease all operations except for the purpose of winding up, (ii) as promptly
as reasonably possible but not more than ten business days thereafter, redeem
100% of the public shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the
trust account including interest earned on the funds held in the trust account
and not previously released to us to pay our franchise and income taxes (less up
to $100,000 of interest to pay dissolution expenses), divided by the number of
then outstanding public shares, which redemption will completely extinguish
public stockholders' rights as stockholders (including the right to receive
further liquidating distributions, if any), subject to applicable law, and
(iii) as promptly as reasonably possible following such redemption, subject to
the approval of our remaining stockholders and our board of directors, dissolve
and liquidate, subject in each case to our obligations under Delaware law to
provide for claims of creditors and the requirements of other applicable law.

Results of Operations

Our entire activity from inception through March 31, 2022 related to our formation, the preparation for our Initial Public Offering, and since the closing of the Initial Public Offering, the search for a prospective initial business combination. We have neither engaged in any operations nor generated any revenues to date. We will not generate any operating revenues until after completion of our initial business combination. We will generate non-operating income in the form of interest income on cash and cash equivalents.

For the three months ended March 31, 2022, we had net income of $3,319,810, which was comprised of the change in the fair value of our warrants of $3,561,000, interest earned on marketable securities held in trust account of $126,179 and interest income of $13, partially offset by operating costs of $367,382. For the period from January 26, 2021 (inception) through March 31, 2021, we had net loss of $932, which was comprised of operating costs of $932.

Liquidity and Capital Resources and Going Concern

As of March 31, 2022, we had approximately $348,707 in our operating bank account, and working capital deficit of approximately $209,762. We intend to use the funds held outside the trust account primarily to pay existing accounts payable, identify and evaluate prospective initial business combination candidates, perform due diligence on prospective target businesses, pay for travel expenditures, select the target business or businesses to merge with or acquire and structure, negotiate and consummate a business combination.

Prior to the completion of our Initial Public Offering, our liquidity needs had been satisfied through a payment from our Sponsor of $25,000 for the founder shares to cover certain offering costs and the loan under an unsecured promissory note from our Sponsor of $300,000. On November 15, 2021, we consummated the Initial Public Offering of 17,250,000 units (including 2,250,000 units issued upon exercise in full by the underwriters of their option to purchase additional units) at a price of $10.00 per unit. Certain of our initial stockholders lent us an aggregate amount of $3,450,000 as of the closing date of our Initial Public Offering at no interest. The proceeds of the Initial Stockholder Loans were added to the trust account and will be used to fund the redemption of our public shares (subject to the requirements of applicable law). The Initial Stockholder Loans shall be repaid in cash or converted into Initial Stockholder Loan Warrants at a conversion price of $1.00 per warrant, at each Initial Stockholder's sole discretion. The Initial Stockholder Loan Warrants will be identical to the Private Placement Warrants sold in connection with our Initial Public Offering. Simultaneously with the closing of our Initial Public Offering, we consummated the sale of 5,450,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant in a private placement to our Initial Stockholders. Among these Private Placement Warrants, 4,360,000 were purchased by our Sponsor and 545,000 were purchased by each of Cowen and Intrepid.

For the three months ended March 31, 2022, net cash used in operating activities was $348,052, consisting of net income of $3,319,810 which is affected by a change in fair value of warrant liabilities of $(3,561,000), and interest earned on marketable securities held in the Trust Account of $126,179.

For the period from January 26, 2021 (inception) through March 31, 2021, net cash used in operating activities was $0, consisting of net income of $(932), and interest earned on marketable securities held in the Trust Account of $0. Changes in operating assets and liabilities provided $932 of cash from operating activities.


                                       23

--------------------------------------------------------------------------------

Table of Contents

Following our Initial Public Offering, the closing of the over-allotment option, the receipt of proceeds from the Initial Stockholder Loans and the sale of the Private Placement Warrants, a total of $175,950,000 was placed in the trust account. We incurred $4,675,360 in transaction costs, including $3,450,000 of underwriting fees and $1,225,360 of other offering costs. The promissory note from our Sponsor was paid in full on November 17, 2021. Subsequent to the completion of our Initial Public Offering, the closing of the over-allotment option, the receipt of proceeds from the Initial Stockholder Loans and the sale of the Private Placement Warrants, our liquidity needs have been satisfied through the proceeds from the consummation of the private placement not held in the trust account.

In addition, in order to finance transaction costs in connection with an intended initial business combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, provide us working capital loans. To date, there were no amounts outstanding under any working capital loans.


Based on the foregoing, management believes that we will have sufficient working
capital and borrowing capacity to meet our needs through the earlier of the
completion of a business combination or one year from the date of the filing of
this Quarterly Report. We do not believe we will need to raise additional funds
in order to meet the expenditures required for operating our business. However
there is a risk that the company's liquidity may not be sufficient, which raises
substantial doubt about the Company's ability to continue as a going concern. As
indicated elsewhere in this Quarterly Report, we have until February 15, 2023 to
consummate a business combination. If our estimate of the costs of identifying a
target business, undertaking
in-depth
due diligence and negotiating a business combination are less than the actual
amount necessary to do so, we may have insufficient funds available to operate
our business prior to our initial business combination. Furthermore, if a
business combination is not consummated by this date and an extension is not
requested by our Sponsor, there will be a mandatory liquidation and subsequent
dissolution of the company. Uncertainty related to the consummation of a
business combination raises substantial doubt about the company's ability to
continue as a going concern. No adjustments have been made to the carrying
amounts of assets or liabilities to reflect a required liquidation after
February 15, 2023.

Off-Balance
Sheet Arrangements

We do not currently have any
off-balance-sheet
arrangements; however, we do have certain contractual arrangements that would
require us to make payments if certain circumstances occur; we refer to these
arrangements as contingent commitments. See Note 6, "Commitments and
Contingencies," to our financial statements included herein for further
discussion of these matters.

Contractual Obligations

Promissory Note-Related Party

On February 22, 2021, the Company issued an unsecured promissory note (the
"Promissory Note"), pursuant to which the Company could borrow up to an
aggregate of $300,000 to cover expenses related to the Initial Public Offering.
The Promissory Note was
non-interest
bearing and was payable on the earlier of (i) December 31, 2021 or (ii) the
consummation of the Initial Public Offering. On November 12, 2021, the Company
repaid the outstanding balance under the Promissory Note.

Business Combination Marketing Agreement

The underwriters of the Company's Initial Public Offering are entitled to a fee of $0.35 per unit, or $6,037,500 in the aggregate (the "Marketing Fee"), which will be payable to the underwriters pursuant to that certain Business Combination Marketing Agreement (the "Business Combination Marketing Agreement"). The Marketing Fee will become payable to the underwriters from the amounts held in the trust account solely in the event that the Company completes a business combination, subject to the terms of the Business Combination Marketing Agreement.


                                       24

--------------------------------------------------------------------------------

Table of Contents

Critical Accounting Policies and Significant Estimates

The preparation of unaudited condensed financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

Net Income (Loss) Per Common Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, "Earnings Per Share." The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. We have not considered the effect of the warrants sold in the Initial Public Offering and the private placement to purchase an aggregate of 14,075,000 shares of our Class A common stock in the calculation of diluted income (loss) per share, since their inclusion would be anti-dilutive under the treasury stock method. The number of weighted average shares of Class B common stock for calculating basic net income (loss) per share was reduced for the effect of an aggregate of 562,500 shares of Class B common stock that were subject to forfeiture if the over-allotment option was not exercised in full or part by the underwriters. Since the contingency was satisfied as of the beginning of the three-month period ended March 31, 2022, diluted income per share of common stock is the same as basic income per share of common stock for the period. Additionally, for the period from January 26, 2021 (inception) through March 31, 2021, the calculation does not consider the effect of the shares subject to forfeiture as they would be anti-dilutive given the net loss position. As a result, for the period from January 26, 2021 (inception) through March 31, 2021, diluted loss per share of common stock and basic loss per share of common stock are the same for the period. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.

Warrant Liabilities

The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant's specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity ("FASB ASC 480") and FASB ASC 815, Derivatives and Hedging ("FASB ASC 815"). The assessment considers whether the warrants are freestanding financial instruments pursuant to FASB ASC 480, meet the definition of a liability pursuant to FASB ASC 480, and whether the warrants meet all of the requirements for equity classification under FASB ASC 815, including whether the warrants are indexed to the Company's own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.



The Public Warrants and the Private Placement Warrants are recognized as
derivative liabilities in accordance with FASB ASC 815. Accordingly, the Company
recognizes the warrant instruments as liabilities at fair value and adjusts the
instruments to fair value at each reporting period until exercised. Changes in
the estimated fair value of the warrants are recognized as a
non-cash
gain or loss on the statement of operations. Upon consummating the Initial
Public Offering on November 15, 2021, the company estimated the fair value of
the warrant derivative liabilities using a Binomial lattice model and
subsequently measured using a Monte Carlo simulation and the Black-Scholes
Option Pricing Model at
period-end.
Subsequently, derivative warrant liabilities are classified as
non-current
as their liquidation is not reasonably expected to require the use of current
assets or require the creation of current liabilities. The determination of fair
value for the warrant liabilities represents a significant estimate made by
management in the unaudited condensed financial statements.

                                       25

--------------------------------------------------------------------------------

Table of Contents

Class A Common Stock Subject to Possible Redemption


The Company accounts for its shares of Class A common stock subject to possible
redemption in accordance with the guidance in FASB ASC 480. Shares of Class A
common stock subject to mandatory redemption (if any) are classified as
liability instruments and are measured at fair value. Conditionally redeemable
shares of common stock (including shares that feature redemption rights that are
either within the control of the holder or subject to redemption upon the
occurrence of uncertain events not solely within the Company's control) are
classified as temporary equity. At all other times, Class A shares of common
stock are classified as shareholders' equity. The Company's shares of Class A
common stock sold in the Initial Public Offering feature certain redemption
rights that are considered to be outside of the Company's control and subject to
the occurrence of uncertain future events. Accordingly, as of March 31, 2022,
17,250,000 shares of Class A common stock subject to possible redemption are
presented as temporary equity, outside of the stockholders' deficit section of
the Company's balance sheets. The Company recognizes changes in redemption value
immediately as they occur and adjusts the carrying value of redeemable common
stock to equal the redemption value at the end of each reporting period. Such
changes are reflected in additional
paid-in
capital, or in the absence of additional capital, in accumulated deficit.

JOBS Act



On April 5, 2012, the Jumpstart Our Business Startups Act of 2012 (the "JOBS
Act") was signed into law. The JOBS Act contains provisions that, among other
things, relax certain reporting requirements for qualifying public companies. We
qualify as an "emerging growth company" and under the JOBS Act are allowed to
comply with new or revised accounting pronouncements based on the effective date
for private (not publicly traded) companies. We are electing to delay the
adoption of new or revised accounting standards, and as a result, we may not
comply with new or revised accounting standards on the relevant dates on which
adoption of such standards is required for
non-emerging
growth companies. As a result, our financial statements may not be comparable to
companies that comply with new or revised accounting pronouncements as of public
company effective dates.

As an "emerging growth company," we are not required to, among other things,
(i) provide an auditor's attestation report on our system of internal controls
over financial reporting pursuant to Section 404, (ii) provide all of the
compensation disclosure that may be required of
non-emerging
growth public companies under the Dodd-Frank Wall Street Reform and Consumer
Protection Act, (iii) comply with any requirement that may be adopted by the
PCAOB regarding mandatory audit firm rotation or a supplement to the auditor's
report providing additional information about the audit and the financial
statements (auditor discussion and analysis), and (iv) disclose certain
executive compensation related items such as the correlation between executive
compensation and performance and comparisons of the Chief Executive Officer's
compensation to median employee compensation. These exemptions will apply for a
period of five years following the completion of our Initial Public Offering or
until we are no longer an "emerging growth company," whichever is earlier.

© Edgar Online, source Glimpses